QIAGEN Appoints Jonathan M. Pratt as Chief Executive Officer
QIAGEN appointed Jonathan M. Pratt as its new Chief Executive Officer, effective September 1, 2026, succeeding Thierry Bernard who will step down and support the transition through year-end. Pratt brings over 25 years of experience, most recently as CEO of Filtration Group and previously at Waters Corporation and Beckman Coulter Life Sciences.
Key figures
- Guidance
- QIAGEN reaffirmed its outlook for the third quarter and full-year 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.